Last update 01 Nov 2024

Enristomig

Overview

Basic Info

Drug Type
Bispecific antibody
Synonyms
INBRX-105 - PDL1x41BB antibody
+ [1]
Mechanism
4-1BB agonists(Tumor necrosis factor receptor superfamily member 9 agonists), 4-1BB inhibitors(Tumor necrosis factor receptor superfamily member 9 inhibitors), PDL1 inhibitors(Programmed death-ligand 1 inhibitors)
Originator Organization
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Thoracic NeoplasmDiscovery-01 Jul 2021
Non-Small Cell Lung CancerDiscovery-01 Jul 2021
Small Cell Lung CancerDiscovery-01 Jul 2021
Adenocarcinoma of EsophagusDiscovery
US
30 Jan 2019
MelanomaDiscovery
US
30 Jan 2019
Metastatic Solid TumorDiscovery
US
30 Jan 2019
Nasopharyngeal CarcinomaDiscovery
US
30 Jan 2019
Oropharyngeal NeoplasmsDiscovery
US
30 Jan 2019
Renal Cell CarcinomaDiscovery
US
30 Jan 2019
Squamous Cell Carcinoma of Head and NeckDiscovery
US
30 Jan 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free